Literature DB >> 10726331

Acute renal failure and rhabdomyolysis after inadvertent intra-arterial infusion of excessive doses of epinephrine during cardiopulmonary resuscitation.

P Eisenburger1, A N Laggner, K Lenz, W Druml.   

Abstract

Severe renal dysfunction or even acute renal failure necessitating renal replacement therapy are rather infrequent observations in patients following cardiopulmonary resuscitation. A low flow situation alone does not seem to be sufficient for renal breakdown and in addition other factors, such as preexisting renal disease, severe infections or congestive heart failure must be present. We report a patient, in whom during cardiopulmonary resuscitation a central venous catheter was placed which inadvertently was located in the aortic arch. Through this malpositioned line increasing and finally excessive amounts of epinephrine (in total 150 mg) were injected because of inadequate therapeutic response. After finally successful resuscitation the patient developed rhabdomyolysis and acute renal failure, which required hemodialyis therapy. Intraarterial infusion of the vasoconstrictor catecholamine obviously caused a critical reduction in renal and skeletal muscle perfusion. Nevertheless, the patient was discharged from hospital in good neurologic condition and with normal renal function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10726331

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  3 in total

1.  A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis.

Authors:  Sean Ekins; Lei Diao; James E Polli
Journal:  Mol Pharm       Date:  2012-02-28       Impact factor: 4.939

Review 2.  Potential factors involved in the causation of rhabdomyolysis following status asthmaticus.

Authors:  Hongmei Qiao; Huanji Cheng; Li Liu; Jianing Yin
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-22       Impact factor: 3.406

3.  Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit.

Authors:  Olivier Boucheix; Robert Blakytny; Gerard Haroutunian; Marie Henriksson; Regent Laporte; Stephane Milano; Torsten M Reinheimer
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.